177 related articles for article (PubMed ID: 16980073)
1. Anti-donor DR103 Immunization in a DRB1*0101 kidney allograft recipient.
Hajji K; Guignier F; Tanter Y; Rifle G; Mousson C
Transplant Proc; 2006 Sep; 38(7):2306-7. PubMed ID: 16980073
[TBL] [Abstract][Full Text] [Related]
2. Anti-HLA antibodies in kidney transplanted patients.
Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
[TBL] [Abstract][Full Text] [Related]
3. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
4. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
5. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
6. The role of DRB1 amino acid residue differences on donor-specific antibody production and acute rejection after cadaveric renal transplant.
Adorno D; Piazza A; Canossi A; Valeri M; Torlone N; Monaco PI; Papola F; Casciani CU
J Biol Regul Homeost Agents; 1999; 13(1):32-6. PubMed ID: 10432439
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
[TBL] [Abstract][Full Text] [Related]
8. Immune responsiveness.
Cook DJ
Clin Transpl; 1988; ():357-63. PubMed ID: 3154485
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR1 is a low responsiveness antigen in human kidney transplant recipients.
Cicciarelli J
Clin Transpl; 1987; ():381-91. PubMed ID: 3154437
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR1 recipients have the highest kidney transplant survival.
Cook DJ; Cecka JM; Terasaki PI
Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
[No Abstract] [Full Text] [Related]
12. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
13. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
[No Abstract] [Full Text] [Related]
16. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR1, -DR5, and -DR8 antigen disparities are associated with acute steroid-resistant rejection and poor kidney graft survival.
Salmela K; von Willebrand E; Kyllönen L; Koskimies S; Isoniemi H; Eklund B; Höckerstedt K; Ahonen J
Transplant Proc; 1991 Feb; 23(1 Pt 2):1272-3. PubMed ID: 1899160
[No Abstract] [Full Text] [Related]
18. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
19. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.
Middleton D; Martin J; Douglas J; McClelland M
Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720
[TBL] [Abstract][Full Text] [Related]
20. Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.
Thorsby E; Pfeffer P; Leivestad T
Transplant Proc; 2004 Mar; 36(2 Suppl):16S-21S. PubMed ID: 15041301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
